Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Atelectasis Neonatal Clear all

Conditions: Neonatal Respiratory Distress
Interventions: Infasurf Aero; Combination Product
Lead sponsor: ONY; Industry
Eligibility: Up to 42 Weeks
U.S. locations: 5
States / cities: Jackson, Mississippi • Buffalo, New York • Greenville, North Carolina + 2 more

Conditions: Bronchopulmonary Disease
Interventions: Patient Registry; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2099
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Respiratory Distress Syndrome (Neonatal), Intubation Complication, Death; Neonatal
Interventions: Infasurf Aero™; Combination Product
Lead sponsor: ONY; Industry
Eligibility: 29 Weeks to 36 Weeks
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 10
States / cities: Phoenix, Arizona • San Diego, California • Jacksonville, Florida + 6 more

Conditions: Pre-Term, Respiratory Distress of Newborn, Premature
Interventions: Point of care lung ultrasound; Diagnostic Test
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 34 Weeks to 36 Weeks
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Respiratory Distress Syndrome, Newborn
Interventions: Surfactant administered via Laryngeal Mask Airway (LMA), standard of care (nasal CPAP and supplemental oxygen); Device · Other
Lead sponsor: University of Virginia; Other
Eligibility: Up to 72 Hours
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Respiratory Distress Syndrome (Neonatal), Respiratory Distress of Newborn
Interventions: Effective oxygen delivery and lung expansion measurement; Device
Lead sponsor: University of Arkansas; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Respiratory Distress Syndrome (Neonatal), Surfactant Deficiency Syndrome Neonatal
Interventions: Video Laryngoscopy, Direct Laryngoscopy; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 0 Hours to 3 Days
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Neonatal Respiratory Distress
Interventions: Simulation; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Neonatal Respiratory Distress
Interventions: RAM Nasal Cannula; Other
Lead sponsor: Englewood Hospital and Medical Center; Other
Eligibility: 28 Weeks to 42 Weeks
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: Respiratory Distress of Newborn
Interventions: Ultrasound; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: Up to 6 Months
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Madison, Wisconsin

Conditions: Respiratory Distress Syndrome (Neonatal), Surfactant
Interventions: Surfactant Administration Through Laryngeal or Supraglottic Airway (SALSA), Continuous Positive Airway Pressure (CPAP); Procedure
Lead sponsor: Sharp HealthCare; Other
Eligibility: 33 Weeks to 38 Weeks
Enrollment: 422 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 3
States / cities: Chula Vista, California • La Mesa, California • San Diego, California

Conditions: Premature Lungs, Respiratory Distress Syndrome, Surfactant Deficiency Syndrome Neonatal
Interventions: Less Invasive Surfactant Administration LISA, Continuous Positive Airway Pressure CPAP; Procedure
Lead sponsor: Sharp HealthCare; Other
Eligibility: 24 Weeks to 29 Weeks
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Irvine, California • Loma Linda, California • San Diego, California

Conditions: Atelectasis Neonatal, Pneumothorax and Air Leak
Interventions: Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT); Other
Lead sponsor: Sharp HealthCare; Other
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Preterm Infants, Respiratory Distress Syndrome (Neonatal), BPD - Bronchopulmonary Dysplasia
Interventions: Pressure Targeted High Flow, CPAP; Procedure
Lead sponsor: University of Texas at Austin; Other
Eligibility: 7 Days to 40 Weeks
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: San Diego, California • Austin, Texas

Conditions: Infant, Premature, Neonatal Respiratory Distress, Oxygen Saturation, Bronchopulmonary Dysplasia
Interventions: Automated Control, Manual Control; Device
Lead sponsor: Vapotherm, Inc.; Industry
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Salt Lake City, Utah • Seattle, Washington

Search by objective public record fields.

Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

Preterm Lung Patient Registry

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates

Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)

How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

Transference of Established Simulated Skills (TEST) Trial

A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)

Lung Ultrasound - Prospective Study

Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants

Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants

Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants

Pressure Targeting During High Flow Therapy in Premature Infants

Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants